Osaka, Japan

Masato Horiuchi


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Toyonaka, JA (1977)
  • Settsu, JP (1999)
  • Osaka, JP (2000 - 2011)

Company Filing History:


Years Active: 1977-2011

Loading Chart...
13 patents (USPTO):Explore Patents

Title: **Masato Horiuchi: Innovator in TNF-α Production Inhibitors**

Introduction

Masato Horiuchi is an accomplished inventor based in Osaka, Japan, known for his significant contributions to the field of pharmaceutical innovations. With a portfolio of 13 patents, Horiuchi specializes in developing compounds that address serious medical conditions, particularly autoimmune diseases.

Latest Patents

Horiuchi's most recent patents focus on TNF-α production inhibitors. These innovative compounds are designed to treat autoimmune diseases like rheumatoid arthritis. One of the key features of these compounds includes a complex formula where components such as A, B, and R represent various chemical structures and substituents. For instance, A can be in the form of —O—, while B may be an alkylene or alkenylene chain that can be modified with oxygen, sulfur, or various aliphatic or aromatic groups. This intricate design showcases Horiuchi's expertise in creating effective therapeutic agents.

Career Highlights

Throughout his career, Masato Horiuchi has consistently pushed the boundaries of pharmaceutical sciences. His groundbreaking work in TNF-α production inhibitors has positioned him as a key figure at Santen Pharmaceutical Co., Ltd., where he continues to innovate and refine treatments for complex medical conditions.

Collaborations

Horiuchi has collaborated with fellow researchers Hiroshi Suhara and Masakazu Ban, contributing to a dynamic team focused on advancing therapeutic solutions. Their combined efforts have led to the development of novel compounds that show promise in improving the lives of those affected by autoimmune disorders.

Conclusion

Masato Horiuchi exemplifies the spirit of innovation, making significant strides in pharmaceutical inventions. His work not only enhances the understanding of autoimmune diseases but also provides hope for effective treatments through his patented inventions. As he continues his work at Santen Pharmaceutical Co., Ltd., the medical field eagerly awaits further developments stemming from his research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…